From Signals to Scale: Defining the Future of Healthtech in DC
Fresh off the insights from J.P. Morgan Healthcare, the DC ecosystem is ready to stress-test what’s next.
Fresh off the insights from J.P. Morgan Healthcare, the DC ecosystem is ready to stress-test what’s next.
Contact Information: DC Tech and Venture Coalition (DCTAV)
Contact: press@dctav.co
Join hundreds of founders, investors, and health system leaders as we return from the JP Morgan Healthcare Conference in San Francisco to turn key healthcare innovation insights into regional action. On March 4, 2026, the DC Tech and Venture Coalition (DCTAV) will host a working forum at the heart of the District to define how innovation is governed, financed, and scaled in 2026.
This isn't just a trend recap it’s a stress test for the future of healthtech and biotech in the DC ecosystem.
We are featuring three curated product demonstrations focused on operational readiness and early commercial traction. These showcases will highlight the builders moving beyond concept to real-world deployment in the healthcare space.
Our sessions move past the hype to provide a critical look at execution and institutional alignment:
• Healthcare in Action: A deep dive into which AI, data, and platform models are deployable today and how health systems are overcoming barriers to scale.
• Regulation as Strategy: Analyzing how reimbursement pathways, payer alignment, and regulatory signals are shaping risk and opportunity for the year ahead.
• Capital with Context: A disciplined look at what investors expect from founders in 2026, focusing on deal structures, valuation, and strategic scale.
• Fireside Chat: "Building in the District" – Explaining why DC is uniquely positioned for healthcare innovation and how founders can leverage the city's institutional density.
Curated networking among founders, investors, health system leaders, policymakers, and platform operators. Light breakfast and facilitated introductions.
This panel will move beyond headline innovation to examine which healthcare and life sciences models are achieving real-world adoption.
Discussion Focus
• Which AI, data, and platform models are deployable today
• How health systems evaluate traction versus promise
• Institutional barriers to scale and how they are being overcome
• Lessons from organizations already operationalizing innovation
This panel will examine how regulatory shifts, reimbursement dynamics, and risk allocation are shaping healthcare and life sciences strategy in the year ahead.
Discussion Focus
• Reimbursement pathways and payer alignment
• Risk, liability, and insurance considerations for emerging technologies
• Regulatory signals founders and investors must understand
• Using compliance as a strategic advantage rather than a constraint
This conversation will explore what it takes to build and scale healthcare and life sciences companies in Washington, DC through accelerator programs, institutional partnerships, and ecosystem support.
Participants
• Keith Camhi, Managing Director, Techstars DC
• Jessica Locke, Kaiser Permanente
• Kevin Morgan, Facilitator
Key Themes
• Why DC is uniquely positioned for healthcare innovation
• Lessons from hosting global startup cohorts locally
• How founders can leverage DC’s institutional density
Three curated product demonstrations focused on real-world deployment, operational readiness, and early commercial traction.
This panel will focus on how investors, financial institutions, and advisors are approaching healthcare and life sciences investments amid evolving market conditions.
Discussion Focus
• Deal structures, valuation discipline, and timing
• What investors expect from founders in 2026
• The role of accelerators and strategic capitalAdvisory perspectives on diligence, scale, and exits
🏥 DC Health Innovation Summit 2026: Healthcare & Life Sciences
📅 Wednesday, March 4, 2026
🕗 8:30 AM – 1:00 PM ET
📍 Downtown Washington, DC